Epidemiology and Treatment Modalities for the Management of Benign Prostatic Hyperplasia

Soum D. Lokeshwar; Benjamin T. Harper; Eric Webb; Andre Jordan; Thomas A. Dykes; Durwood E. Neal Jr; Martha K. Terris; Zachary Klaassen


Transl Androl Urol. 2019;8(5):529-539. 

In This Article


The increase in the prevalence of BPH in recent decades has been met with a growth of treatment options. Physicians today must determine which management modality is optimal for their particular patient. However, first physicians must decide if a patient should be managed on medical therapy or undergo surgical intervention. This decision is based on both patient and physician preference and surgical candidacy. With the changing nature of modifiable risk factors for BPH, further research into optimizing treatment is ongoing.